Log in to save to my catalogue

miR-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in Parkinson’s disease

miR-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in Parkinson’s disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6683159

miR-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in Parkinson’s disease

About this item

Full title

miR-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in Parkinson’s disease

Publisher

London: Nature Publishing Group UK

Journal title

Cell death & disease, 2019-08, Vol.10 (8), p.589-15, Article 589

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

A major hallmark of Parkinson’s disease (PD) is the degeneration of dopaminergic neurons in the substantia nigra, and the causative mechanism is thought to be the activation of programmed neuronal death. Necroptosis is a regulated process of cell death triggered by RIPK1. Although the pathophysiology of PD has been studied extensively, the cellular...

Alternative Titles

Full title

miR-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in Parkinson’s disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6683159

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6683159

Other Identifiers

ISSN

2041-4889

E-ISSN

2041-4889

DOI

10.1038/s41419-019-1809-5

How to access this item